Purification of the first component of human complement and its subunit C1 esterase. (Q54462861)

30 May 2018

title

Purification of the first component of human complement and its subunit C1 esterase. (English)

1 reference

30 May 2018

author name string

Bing DH

series ordinal

1

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 January 1974

1 reference

30 May 2018

published in

Methods in Enzymology

1 reference

30 May 2018

volume

34

1 reference

30 May 2018

page(s)

731-746

1 reference

30 May 2018

The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Nature of the active site of a subunit of the first component of human complement

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

The nature of human Cl-esterase: its role in the complement reaction and the thermodynamic parameters associated with its action on some synthetic substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Influence of aliphatic amines on the interaction of human C′1 with EAC′4

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Irreversible enzyme inhibitors. 180. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy) benzamidine and phenoxyacetamide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluoride

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Chromatographic resolution of the first component of human complement into three activities

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Inactivation of the first component of human complement by m-(o-(2-chloro-5-fluorosulfonylphenylureido)-phenoxybutoxy)benzamidine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

The derivatization of cross-linked polyacrylamide beads. Controlled introduction of functional groups for the preparation of special-purpose, biochemical adsorbents

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Adsorbents for affinity chromatography. Use of N-hydroxysuccinimide esters of agarose

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Purification of the human complement protein C1s̄ by affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Purification of wheat proteases by affinity chromatography on hemoglobin-sepharose column

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

IMMUNOCHEMICAL STUDIES ON BLOOD GROUPS. XXX. CLEAVAGE OF A, B, AND H BLOOD-GROUP SUBSTANCES BY ALKALI

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

Efficiency of the First Component of Complement (C′1) in the Hemolytic Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2874%2934095-5

7 January 2021

10.1016/S0076-6879(74)34095-5

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018